Although the FDA and American College of Obstetricians and Gynecologists strongly advise against the use of cannabidiol (CBD) during pregnancy, CBD is widely available and marketed to pregnant women. The effects of CBD on human embryonic and fetal development are unknown, but preclinical studies indicate that there may be teratogenic effects. More data are needed on the prevalence